- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Dana-Farber/Brigham and Women's Cancer Center
Total 569 results
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Hodgkin's DiseaseUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalTerminatedBurkitt Lymphoma | Non-Hodgkins Lymphoma | Atypical Burkitt LymphomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedHeart FailureUnited States, Canada
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedNasopharyngeal CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedEarly-Stage Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedStomach Cancer | Gastric Cancer | Gastro-esophageal Junction CancerUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Brigham and Women's HospitalTerminatedChronic Graft-versus-host DiseaseUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruiting
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteBoston Children's Hospital; Brigham and Women's HospitalCompletedMyelogenous Leukemia, AcuteUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedOvarian Cancer | Peritoneal Carcinoma | Tubal CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedAdenocarcinoma of Stomach | Adenocarcinoma of GE Junction | Adenocarcinoma of EsophagusUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNon-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruitingSmoking Cessation | Lung CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Spaulding Rehabilitation HospitalCompletedBreast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalTerminatedRectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Brigham and Women's HospitalCompletedC-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck NeoplasmsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedColorectal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; AmgenCompletedBladder Cancer | Muscle-invasive Bladder CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; AbbottCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pharmacia; Brigham and Women's HospitalCompletedEsophageal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's HospitalCompletedMyelofibrosis | Chronic Myelomonocytic Leukemia | Myeloid Metaplasia | Agnogenic Myeloid MetaplasiaUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedGlioblastoma | Brain TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedBreast Cancer | Hodgkin's DiseaseUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedSquamous Cell Carcinoma | Carcinoma of Head/NeckUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedMixed Mullerian Tumors of the UterusUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; University of Massachusetts, BostonCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; AstraZeneca; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
Beth Israel Deaconess Medical CenterNovartis; Pfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedRenal Cell CarcinomaUnited States